Current Aspects of Epidemiology, Pathogenesis and Treatment in Diabetic Macular Edema

Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy // Semin Ophthalmol., 1999;14:223-232Search in Google Scholar

Bhagat N, Grigorian RA and Tutela A. Diabetic macular edema: pathogenesis and treatment // Survey of Ophthalmology, 2009; 54: 1-3210.1016/j.survophthal.2008.10.001Search in Google Scholar

Cunha-Vaz J. G. Pathophysiology of diabetic retinopathy // British Joiurnial of Ophlthalmology, 1978; 62, 351-35510.1136/bjo.62.6.351Search in Google Scholar

Donald R. Senger. Vascular Endothelial Growth Factor: Much More than an Angiogenesis Factor // Molecular Biology of the Cell, 2010; 21(3): 377-379Search in Google Scholar

Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: ETDRS report no. 4. // Int Ophthalmol Clin, 1987; 27:265-7210.1097/00004397-198702740-00006Search in Google Scholar

Engler CB, Sander B, Larsen M, Koefoed P, Parving HH, Lund-Andersen H. Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier // Acta Ophthalmol (Copenh), 1994; 72:663-667.10.1111/j.1755-3768.1994.tb04676.xSearch in Google Scholar

Hans-Peter Hammes, Jihong Lin, Oliver Renner, Moshe Shani, Andrea Lundqvist, Christer Betsholtz, Michael Brownlee, and Urban Deutsch. Pericytes and the Pathogenesis of Diabetic Retinopathy // Diabetes, 2002; 51(10):3107-1210.2337/diabetes.51.10.3107Search in Google Scholar

Kang SW, Park CY, Ham DI. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema // Am J Ophthalmol., 2004; 137(2):313-22Search in Google Scholar

Klein R, Klein B, Moss S, Davis M, DeMets D. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IV: diabetic macular edema // Ophthalmology, 1984; 91:1464-147410.1016/S0161-6420(84)34102-1Search in Google Scholar

Koyano S, Araie M, Eguchi S. Movement of fluorescein and its glucuronide across retinal pigment epithelium-choroid // Invest Ophthalmol Vis Sci, 1993; 34:531-538.Search in Google Scholar

Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C. Intravitreal triamcinolone for refractory diabetic macular edema // Ophthalmology, 2002 May; 109(5):920-710.1016/S0161-6420(02)00975-2Search in Google Scholar

Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS. Diabetes trends in the U. S.: 1990-1998 // Diabetes Care, 2000; 23:1278-1283Search in Google Scholar

Moss S, Klein R, Klein B. The 14-year incidence of visual loss in a diabetic population // Ophthalmology, 1998; 105:998-100310.1016/S0161-6420(98)96025-0Search in Google Scholar

Moss SE, Klein R and Klein BE. The 14-year incidence of visual loss in diabetic population // Ophthalmology, 1995; 97: 415-419Search in Google Scholar

Negi A and Vernon SA. An overview of the eye in diabetes // Journal of the Royal Society of Medicine, 2003; 96:266-27210.1177/014107680309600603Search in Google Scholar

Nguyen QD, Tatlipinar S, Shah SM, Haller JA, Quinlan E, Sung J, Zimmer-Galler I, Do DV, Campochiaro PA. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema // Am J Ophthalmol, 2006;142(6): 961-910.1016/j.ajo.2006.06.06817046701Search in Google Scholar

Pendergast SD, Hassan TS, Williams GA, Cox MS, Margherio RR, Ferrone PJ, Garretson BR, Trese MT. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid // Am J Ophthalmol, 2000; 130(2):178-8610.1016/S0002-9394(00)00472-4Search in Google Scholar

Peter Kroll, Marburg. Current Aspects of Pathogenesis and Treatment in Diabetic Retinopathy // Ophthalmologica 2007; 221:7710.1159/isbn.978-3-318-01449-5Search in Google Scholar

PKC-DRS2 Group, Aiello LP, Davis MD, Girach A, Kles KA, Milton RC, Sheetz MJ, Vignati L, Zhi XE. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy // Ophthalmology, 2006;113(12):2221-3010.1016/j.ophtha.2006.07.032Search in Google Scholar

Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration // Ophthalmic Surg Lasers Imaging. 2005; 36:331-33510.3928/1542-8877-20050701-14Search in Google Scholar

Sander B, Larsen M, Moldow B, Lund-Andersen H. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier // Invest Ophthalmol Vis Sci 2001;42: 433-438.Search in Google Scholar

Schepens CL, Avila MP, Jalkh AE, Trempe CL. Role of the vitreous in cystoid macular edema // Surv Ophthalmol, 1984; 28(suppl):499-504.10.1016/0039-6257(84)90232-7Search in Google Scholar

Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate // Ophthalmology 1996; 103: 1820-8.10.1016/S0161-6420(96)30420-XSearch in Google Scholar

Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. // Arch Ophthalmol 1985; 103:1796-80610.1001/archopht.1985.01050120030015Search in Google Scholar

Vinores S, Youssri A, Luna J, et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease // Histol Histopathol 1997; 12:99-109Search in Google Scholar